Mendbrisk Pharmaceuticals Private Limited
About Mendbrisk Pharmaceuticals Private Limited
Data last updated:
Mendbrisk Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 05 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24100MH2014PTC259997. Its GSTIN is 27AAJCM5244N2ZX (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dhirendra Dinakar Kukde and Amit Turrey.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No. 6011/M/36 Sakkardara Bank Colony Durga Nagar, Nagpur, Maharashtra, India – 440024.
As per the financials filed for FY 2021, the company reported a revenue of ₹10.83 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net loss of ₹7,979 (net margin -0.7%) and EBITDA of ₹53,834 (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 29% over five years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mendbrisk Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 6011/M/36 Sakkardara Bank Colony Durga Nagar, Nagpur, Maharashtra, India – 440024
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Mendbrisk Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mendbrisk Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mendbrisk Pharmaceuticals Private Limited, buy the company report.
Financials of Mendbrisk Pharmaceuticals Private Limited
FY 2021 filings availableMendbrisk Pharmaceuticals Private Limited reported revenue of ₹10.83 Lakh (down 10% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 29%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹53,834 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7,979 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | -0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mendbrisk Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mendbrisk Pharmaceuticals Private Limited
Mendbrisk Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhirendra Dinakar Kukde | Director | 11 Jul 2018 | 8 Years 3 Months | Current |
| Amit Turrey | Director | 05 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Mendbrisk Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zubin Pharmaceuticals Private Limited | ₹10.84 Lakh (FY 2018) | -6.0% | New Delhi, Delhi, India | |||
| Mendbrisk Pharmaceuticals Private Limitedthis company | ₹10.83 Lakh (FY 2021) | -₹7,979 | -0.7% | -10.0% | Nagpur, Maharashtra, India | |
| Medizoid Pharmaceuticals Private Limited | ₹10.83 Lakh (FY 2024) | -17.0% | Nalagarh, Himachal Pradesh, India | |||
| Shree Karni Pharmaceuticals Private Limited | ₹10.82 Lakh (FY 2024) | Jodhpur, Rajasthan, India | ||||
| Annulus Pharmaceuticals Private Limited | ₹10.81 Lakh (FY 2025) | -14.0% | Patna, Bihar, India |
To see the full peer comparison of Mendbrisk Pharmaceuticals Private Limited, buy the company report.
Auditor
Mendbrisk Pharmaceuticals Private Limited is audited by MTS & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MTS & ASSOCIATES | FY 2017 | 130510W |
Shareholding
The shareholding of Mendbrisk Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mendbrisk Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Mar 2019 | 100255384 | Others | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mendbrisk Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mendbrisk Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mendbrisk Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCM5244N2ZX | Maharashtra | Active | 30 Jul 2019 |
To see the full GST registrations and return filing status of Mendbrisk Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mendbrisk Pharmaceuticals Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Atish Laxman Pardikar ceased to be Director on 11 Jul 2018.
Frequently asked questions
Mendbrisk Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 05 December 2014 (12+ years old) and is registered under CIN U24100MH2014PTC259997.
Mendbrisk Pharmaceuticals has 2 current directors:
- Dhirendra Dinakar Kukde - Director
- Amit Turrey - Director
The latest financial statements of Mendbrisk Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Mendbrisk Pharmaceuticals is 27AAJCM5244N2ZX, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Mendbrisk Pharmaceuticals is U24100MH2014PTC259997. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mendbrisk Pharmaceuticals was incorporated on 05 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Mendbrisk Pharmaceuticals by revenue are Zubin Pharmaceuticals Private Limited, Medizoid Pharmaceuticals Private Limited, Shree Karni Pharmaceuticals Private Limited, Annulus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Atish Laxman Pardikar ceased to be Director on 11 Jul 2018. Dhirendra Dinakar Kukde was appointed as Director on 11 Jul 2018. Dhirendra Dinakar Kukde ceased to be Director on 14 Jan 2016. Mendbrisk Pharmaceuticals has 4 board changes on record in total.
The registered office of Mendbrisk Pharmaceuticals is at Plot No. 6011M36 Sakkardara Bank Colony Durga Nagar, Nagpur, Maharashtra, India – 440024.
Mendbrisk Pharmaceuticals operates in the trading industry, in the wholesale segment.
Mendbrisk Pharmaceuticals has open charges of ₹7 Lakh and no satisfied charges on record as per latest MCA filings.